Mismatch repair-deficient (DMMR)

Clinical trials for Mismatch repair-deficient (DMMR) explained in plain language.

Never miss a new study

Get alerted when new Mismatch repair-deficient (DMMR) trials appear

Sign up with your email to follow new studies for Mismatch repair-deficient (DMMR), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet finished but already full! 1

New drug combo aims to shrink tough colorectal tumors before surgery

Disease control Recruiting now

This phase 2 trial is testing whether giving the immunotherapy drug toripalimab, with or without the anti-inflammatory drug celecoxib, before surgery can improve outcomes for people with a specific type of colorectal cancer (dMMR/MSI-H). About 270 participants will receive the dr…

Matched conditions: MISMATCH REPAIR-DEFICIENT (DMMR)

Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control

Last updated Jun 27, 2026 07:58 UTC

Mismatch repair-deficient (DMMR)

Get alerted when new Mismatch repair-deficient (DMMR) trials appear

New drug combo aims to shrink tough colorectal tumors before surgery